Discontinue the drug approximately 1 to 2 weeks prior to elective surgery for the majority of patients
Study Objectives To evaluate if semaglutide 2.4 mg subcutaneously once weekly is superior to placebo when added to standard of care for preventing major adverse cardiovascular events in patients with established CVD and overweight or obesity but without diabetes
As a result, only 24% of diabetes patients remain persistent with GLP-1 therapy after one year
The profound, crushing exhaustion, the unpredictable and terrifying symptom flares, and the isolating cognitive fog are not just 'in your head' or a sign of deconditioningthey are the very real, measurable manifestations of a body locked in a severe state of cellular energy depletion and systemic oxidative stress
Miss weekly doses if surgery occurs within seven days of the last injection, recording specific dates
Which leads to the bigger truth: If you want tirzepatide to work, you need a medically supervised injectable formulation, not an unverified pill